Respivant Sciences GmbH
10Patents
10Active
10Granted
47Portfolio score
Filing activity: Aug 5, 2016 → Jul 10, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10238628B2 | Mast cell stabilizers treatment for systemic disorders | Emerging Cross-Sectional Technologies | 6 | Active |
| US10596146B2 | Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders | Emerging Cross-Sectional Technologies | 0 | Active |
| US10265267B2 | Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis | Human Necessities | 0 | Active |
| US10561635B2 | Cromolyn compositions for treatment of pulmonary fibrosis | Human Necessities | 0 | Active |
| US10835512B2 | Methods of treating respiratory syncytial virus infections | Human Necessities | 0 | Active |
| US10265296B2 | Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders | Emerging Cross-Sectional Technologies | 0 | Active |
| US10583113B2 | Cromolyn compositions for treatment of pulmonary fibrosis | Human Necessities | 0 | Active |
| US10391078B2 | Methods for the treatment of mast cell related disorders with mast cell stabilizers | Human Necessities | 0 | Active |
| US10463613B2 | Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis | Human Necessities | 0 | Active |
| US10238625B2 | Methods for the treatment of mast cell related disorders with mast cell stabilizers | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.